← Leaderboards
Naijie Jing
Baylor College Of Medicine
$1,849,134
Attributed
$1,849,134
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $289.3K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,849,134 · 2
By mechanism
R01$1,849,134 · 2
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Timothy C Thompson$13,464,867
- David John Tweardy$14,168,425
- Masahiro Higuchi$1,897,784
- Russell M Lebovitz$174,672
- Ming-Jer Tsai$12,896,999
Others in their field
Top investigators on “Oligonucleotides”
- Monte Westerfield · University Of Oregon$78,765,009
- David Heimbrook · Leidos Biomedical Research, Inc.$73,743,088
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Randall J Bateman · Washington University$63,044,576
- Larry Arthur$39,727,172
- Ronald Wayne Davis · Stanford University$38,345,338
Research focus
OligonucleotidesDna BindingCancer TherapyCombined Modality TherapyDimerAndrogen Independent Prostate CancerApoptosisAndrogensAmericanClinical TrialsAntitumor AgentCancer CellCancer DiagnosisCancer EtiologyClinical ResearchCarcinomaApoptoticCell ProliferationCellsCessation Of LifeBaseAccountingBinding (Molecular Function)Design
Grant awards (7)
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy$280,899
R01 · FY2009 · CA · contact PI
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy$280,899
R01 · FY2008 · CA · contact PI
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy$280,899
R01 · FY2007 · CA · contact PI
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy$289,288
R01 · FY2006 · CA · contact PI
A Novel Inhibitor of Stat3 for Prostate Cancer Therapy$286,257
R01 · FY2005 · CA
DEVELOPING A POTENT INHIBITOR OF HIV-I INTEGRASE$218,518
R01 · FY2001 · GM
DEVELOPING A POTENT INHIBITOR OF HIV-I INTEGRASE$212,374
R01 · FY2000 · GM